Delivery Order SPE2DB20D2014-SPE2DB25FB18L
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,980.96 firm fixed price delivery order covers the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,757.64, is for the delivery of the pharmaceutical product ADBRY 150 MG/ML SYRINGE. The contract has an ultimate completion date of June 4, 2024 and is a Firm Fixed Price Delivery Order. There was no set-aside used for this award. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 firm fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product - ADBRY 150 MG/ML SYRINGEML. The order has a ceiling value of $17,638.32 and a period of performance through August 13, 2024. It is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides a broad range of medical commodities to support military...
This federal contract award is for the delivery of medical supplies, specifically ADBRY 150 MG/ML syringes, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,031.42 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 29, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,947.12 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML. The contract has a firm fixed price pricing type and an ultimate completion date of June 4, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to the Department of Defense...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,297.57 fixed-price delivery order contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of May 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $2,041.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price contract. The award was not designated with a set-aside requirement, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $17,238.42 and a period of performance through January 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This federal contract award is for the delivery of medical supplies, specifically Adbry 150 mg/ml syringes, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,573.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of December 22, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...